Image
FIGURE 4 from Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients
| العنوان: | FIGURE 4 from Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients |
|---|---|
| المؤلفون: | Tomoyuki Satake, Shunsuke Kondo, Noriko Tanabe, Takaaki Mizuno, Yuki Katsuya, Jun Sato, Takafumi Koyama, Tatsuya Yoshida, Makoto Hirata, Noboru Yamamoto |
| سنة النشر: | 2023 |
| مصطلحات موضوعية: | Cancer, Cancer Biology, Clinical Research and Trials, Methods and Technology, Epidemiology, Precision Medicine, Genetics Of Cancer Risk & Outcome, Familial and hereditary cancers, Oncogenes & Tumor Suppressors, BRCA family, p53, Gene Technologies, Comparative genomics, Gynecological Cancers, Ovarian cancer |
| الوصف: | A, Distribution of germline and somatic variants categorized as pathogenic in the OncoGuide NOP. CSGs that were subject to PGV reporting in NOP Ver.2 were analyzed using only the NOP Ver.2 data, and CSGs that were subject to PGV reporting in NOP Ver.1 were analyzed using the NOP data for the entire period. Numbers in the graph indicate the number of variants. B, Proportion of pathogenic variants in FoundationOne CDx recommended for germline-focused analysis using European Society for Medical Oncology recommendations. Numbers in the graph indicate the number of variants. |
| نوع الوثيقة: | still image |
| اللغة: | unknown |
| Relation: | https://figshare.com/articles/figure/FIGURE_4_from_Pathogenic_Germline_Variants_in_BRCA1_2_and_p53_Identified_by_Real-world_Comprehensive_Cancer_Genome_Profiling_Tests_in_Asian_Patients/24560114 |
| DOI: | 10.1158/2767-9764.24560114.v1 |
| الاتاحة: | https://doi.org/10.1158/2767-9764.24560114.v1 https://figshare.com/articles/figure/FIGURE_4_from_Pathogenic_Germline_Variants_in_BRCA1_2_and_p53_Identified_by_Real-world_Comprehensive_Cancer_Genome_Profiling_Tests_in_Asian_Patients/24560114 |
| Rights: | CC BY |
| رقم الانضمام: | edsbas.BCB37E88 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.BCB37E88 883 3 Image image 882.976379394531 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.BCB37E88&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.1158/2767-9764.24560114.v1# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => FIGURE 4 from Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Tomoyuki+Satake%22">Tomoyuki Satake</searchLink><br /><searchLink fieldCode="AR" term="%22Shunsuke+Kondo%22">Shunsuke Kondo</searchLink><br /><searchLink fieldCode="AR" term="%22Noriko+Tanabe%22">Noriko Tanabe</searchLink><br /><searchLink fieldCode="AR" term="%22Takaaki+Mizuno%22">Takaaki Mizuno</searchLink><br /><searchLink fieldCode="AR" term="%22Yuki+Katsuya%22">Yuki Katsuya</searchLink><br /><searchLink fieldCode="AR" term="%22Jun+Sato%22">Jun Sato</searchLink><br /><searchLink fieldCode="AR" term="%22Takafumi+Koyama%22">Takafumi Koyama</searchLink><br /><searchLink fieldCode="AR" term="%22Tatsuya+Yoshida%22">Tatsuya Yoshida</searchLink><br /><searchLink fieldCode="AR" term="%22Makoto+Hirata%22">Makoto Hirata</searchLink><br /><searchLink fieldCode="AR" term="%22Noboru+Yamamoto%22">Noboru Yamamoto</searchLink> ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2023 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Cancer%22">Cancer</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+Biology%22">Cancer Biology</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+Research+and+Trials%22">Clinical Research and Trials</searchLink><br /><searchLink fieldCode="DE" term="%22Methods+and+Technology%22">Methods and Technology</searchLink><br /><searchLink fieldCode="DE" term="%22Epidemiology%22">Epidemiology</searchLink><br /><searchLink fieldCode="DE" term="%22Precision+Medicine%22">Precision Medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Genetics+Of+Cancer+Risk+%26+Outcome%22">Genetics Of Cancer Risk & Outcome</searchLink><br /><searchLink fieldCode="DE" term="%22Familial+and+hereditary+cancers%22">Familial and hereditary cancers</searchLink><br /><searchLink fieldCode="DE" term="%22Oncogenes+%26+Tumor+Suppressors%22">Oncogenes & Tumor Suppressors</searchLink><br /><searchLink fieldCode="DE" term="%22BRCA+family%22">BRCA family</searchLink><br /><searchLink fieldCode="DE" term="%22p53%22">p53</searchLink><br /><searchLink fieldCode="DE" term="%22Gene+Technologies%22">Gene Technologies</searchLink><br /><searchLink fieldCode="DE" term="%22Comparative+genomics%22">Comparative genomics</searchLink><br /><searchLink fieldCode="DE" term="%22Gynecological+Cancers%22">Gynecological Cancers</searchLink><br /><searchLink fieldCode="DE" term="%22Ovarian+cancer%22">Ovarian cancer</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => A, Distribution of germline and somatic variants categorized as pathogenic in the OncoGuide NOP. CSGs that were subject to PGV reporting in NOP Ver.2 were analyzed using only the NOP Ver.2 data, and CSGs that were subject to PGV reporting in NOP Ver.1 were analyzed using the NOP data for the entire period. Numbers in the graph indicate the number of variants. B, Proportion of pathogenic variants in FoundationOne CDx recommended for germline-focused analysis using European Society for Medical Oncology recommendations. Numbers in the graph indicate the number of variants. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => still image ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => unknown ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => https://figshare.com/articles/figure/FIGURE_4_from_Pathogenic_Germline_Variants_in_BRCA1_2_and_p53_Identified_by_Real-world_Comprehensive_Cancer_Genome_Profiling_Tests_in_Asian_Patients/24560114 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1158/2767-9764.24560114.v1 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1158/2767-9764.24560114.v1<br />https://figshare.com/articles/figure/FIGURE_4_from_Pathogenic_Germline_Variants_in_BRCA1_2_and_p53_Identified_by_Real-world_Comprehensive_Cancer_Genome_Profiling_Tests_in_Asian_Patients/24560114 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => CC BY ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.BCB37E88 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1158/2767-9764.24560114.v1
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => unknown
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Cancer
[Type] => general
)
[1] => Array
(
[SubjectFull] => Cancer Biology
[Type] => general
)
[2] => Array
(
[SubjectFull] => Clinical Research and Trials
[Type] => general
)
[3] => Array
(
[SubjectFull] => Methods and Technology
[Type] => general
)
[4] => Array
(
[SubjectFull] => Epidemiology
[Type] => general
)
[5] => Array
(
[SubjectFull] => Precision Medicine
[Type] => general
)
[6] => Array
(
[SubjectFull] => Genetics Of Cancer Risk & Outcome
[Type] => general
)
[7] => Array
(
[SubjectFull] => Familial and hereditary cancers
[Type] => general
)
[8] => Array
(
[SubjectFull] => Oncogenes & Tumor Suppressors
[Type] => general
)
[9] => Array
(
[SubjectFull] => BRCA family
[Type] => general
)
[10] => Array
(
[SubjectFull] => p53
[Type] => general
)
[11] => Array
(
[SubjectFull] => Gene Technologies
[Type] => general
)
[12] => Array
(
[SubjectFull] => Comparative genomics
[Type] => general
)
[13] => Array
(
[SubjectFull] => Gynecological Cancers
[Type] => general
)
[14] => Array
(
[SubjectFull] => Ovarian cancer
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => FIGURE 4 from Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tomoyuki Satake
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shunsuke Kondo
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Noriko Tanabe
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Takaaki Mizuno
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yuki Katsuya
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jun Sato
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Takafumi Koyama
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tatsuya Yoshida
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Makoto Hirata
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Noboru Yamamoto
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2023
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
)
)
)
)
)
|
| IllustrationInfo |